PRVT

----

Weekly Recap | KKR -0.87%, most brokers rate it buy

LongbridgeAII'm LongbridgeAI, I can summarize articles.

KKR closed the week at $107.73, down 0.87% from the prior Friday’s close of $108.68. The S&P 500 added 0.09% over the same span, leaving KKR roughly 0.96 percentage points behind. The stock spiked to $111.00 on Monday (Aug 31), slid to $105.50 on Tuesday (Sep 1), then chopped between $105.75 and $110.89 through Thursday before settling at $107.73 on Friday (Sep 4). Weekly amplitude was 5.03%. In after-hours trade the latest quote printed $109.60.

The Week

KKR closed the week at $107.73, down 0.87% from the prior Friday’s close of $108.68. The S&P 500 added 0.09% over the same span, leaving KKR roughly 0.96 percentage points behind. The stock spiked to $111.00 on Monday (Aug 31), slid to $105.50 on Tuesday (Sep 1), then chopped between $105.75 and $110.89 through Thursday before settling at $107.73 on Friday (Sep 4). Weekly amplitude was 5.03%. In after-hours trade the latest quote printed $109.60.

Key Events

KKR packed the week with realisations and new positioning. On Tuesday (Sep 1), reports said KKR sold USI Insurance on the NYSE in a deal valued at about $16.7 billion, with KKR set to net roughly $3.3 billion in cash; the same day KKR-backed Wella filed for a US IPO with KKR as underwriter. KKR also agreed to buy 50% of TotalEnergies’ 1.2-GW European renewables portfolio for an enterprise value of EUR 1.8 billion. On Wednesday (Sep 2), the KKR-Singtel consortium completed its acquisition of STTGDC, and sources said KKR would buy A1 Garage Door Service for around $2 billion; KKR also hired former Equinix and AES executives to advance its $10 billion AI data-centre project. On Thursday, Netspi and Synack announced a merger. On Friday (Sep 4), KKR agreed to sell a 10% Nordic Bioscience stake to founder Claus Christiansen and invested in Malaysian healthcare platform Avisena Healthcare. One material filing surfaced this week: a Form 144 for KKR & Co. Inc.

Analyst Ratings

Coverage is broad. Of 22 analysts, 12 rate the stock buy, 7 rate it overweight, and 3 rate it hold; none rate it underweight or sell. The consensus rating is buy, and the consensus target price is $127.98, about 18.8% above the current level of $107.73. Targets range from $105.00 to $166.00, a wide spread. KKR ranks 2nd among 109 firms in the asset management and custody banking industry.

The Week Ahead

On the macro calendar, NFIB small business optimism lands Tuesday (Sep 8) after a prior reading of 99.8. Thursday (Sep 10) is heavier: initial jobless claims carry a prior of 206 and a forecast of 205; final demand PPI shows a prior of 0 month-over-month against a forecast of 0.4; core final demand PPI shows a prior of 0.2 against 0.3; existing home sales, wholesale sales, and EIA natural gas storage changes also land that day. KKR has no scheduled earnings or major events of its own next week. Watch for progress on the Wella IPO, the cash redeployment after the USI close, and the build-out of the AI data-centre platform.

In Short

KKR executed several disposals and new commitments this week, while the ratings backdrop stays positive with a consensus target about 18.8% above spot. The stock still edged lower, and the latest session showed large-lot money as a net seller (large inflow 409.04, large outflow 681.26). Valuation stands at about 3.39x book and 32.34x earnings, with turnover at 0.54%. The tension is between active deal-making and supportive analyst views on one side, and short-term outflow plus a share price that has not yet reflected the target gap on the other. The next read is how quickly USI cash is redeployed and whether the data-centre and healthcare platforms gain incremental recognition.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Login to unlock2,811characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.